Picture of Tango Therapeutics logo

TNGX — Tango Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Tango Therapeutics to stop development of cancer therapy

May 23 (Reuters) - Tango Therapeutics  TNGX.O  said on
Thursday it would stop the development of its experimental
cancer therapy due to liver toxicity experienced by patients in
an early-to-mid stage trial.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi
Majumdar)
 ((Mariam.ESunny@thomsonreuters.com;))

Recent news on Tango Therapeutics

See all news